Home/Filings/4/0001104659-23-079686
4//SEC Filing

Carter Todd Alfred 4

Accession 0001104659-23-079686

CIK 0001640266other

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 4:42 PM ET

Size

4.8 KB

Accession

0001104659-23-079686

Insider Transaction Report

Form 4
Period: 2023-07-06
Carter Todd Alfred
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2023-07-06$10.80/sh5,500$59,40059,860 total
Footnotes (1)
  • [F1]The reported sale of 5,500 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0001944011

Filing Metadata

Form type
4
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:42 PM ET
Size
4.8 KB